ASEAN Dialysis Concentrates and Solutions Market Outlook (2021-2031)

The ASEAN dialysis concentrates and solutions market size is expected to reach US$ 125.0 million by 2031 from US$ 92.0 million in 2024. The market is estimated to record a CAGR of 4.5% from 2025 to 2031.

Executive Summary and ASEAN Dialysis Concentrates and Solutions Market Analysis:

The ASEAN dialysis concentrates and solutions market is in a high-growth phase, emerging as a strategically important region. Expansion is driven by rising dialysis sessions, increasing customization of dialysis compositions, and strong government support in developing economies. Growth prospects are reinforced by higher disposable incomes, the rising prevalence of lifestyle-related diseases, and sustained public investment in healthcare. Currently, in-center hemodialysis dominates treatment, reflecting the market’s developing stage. However, improving economic conditions and growing patient awareness are creating opportunities for advanced care solutions. Despite this positive trajectory, challenges persist—high treatment costs and inconsistent reimbursement policies across countries remain key barriers. Nevertheless, the region continues to prioritize healthcare improvements and address the growing burden of chronic kidney disease, signaling strong long-term potential.

ASEAN Dialysis Concentrates and Solutions Market Segmentation Analysis

Key segments that contributed to the derivation of the dialysis concentrates and solutions market analysis are product, application, and end user.

• By product, the dialysis concentrates and solutions market is segmented into acid concentrates, bicarbonate concentrates, powdered concentrates, dialysate, and electrolyte solutions. Acid concentrates dominated the market in 2024, driven by their critical role and high-volume utilization as a core component in hemodialysis—the predominant treatment modality across countries in ASEAN.
• In terms of application, the market is segmented into hemodialysis and peritoneal dialysis. Hemodialysis accounted for a larger share in 2024, driven by its long-standing position as the primary treatment for end-stage renal disease (ESRD). This dominance is supported by a substantial patient base and well-established, publicly funded clinical infrastructure across the region.
• By end user, the market is segmented into in-center dialysis settings and home care settings. In-center dialysis dominated the market in 2024, driven by the high prevalence of advanced-stage patients with comorbidities requiring continuous medical supervision. Limited infrastructure and inadequate patient training for home-based care in many parts of the region further reinforce this segment’s leadership.

ASEAN Dialysis Concentrates and Solutions Market Outlook

Several emerging trends are supporting a promising future for the ASEAN dialysis concentrates and solutions market. The most prominent is the increasing adoption of PD due to its cost-effectiveness and convenience compared to in-center hemodialysis. It is also better suited to the geography and dispersed communities in the region. This has put strong pressure on demand for PD solutions and consumables, further evidenced by government and healthcare provider initiatives that raise awareness about the suitability of PD as an option. Other emerging growth pockets include telehealth and remote monitoring for care delivery at home, especially in areas where healthcare access is poor. These blended innovations agree with the broader focus on the prevention and early detection of kidney diseases, shaping a holistic approach toward renal health management. The geographical expansion has started beyond urban centers, with acceleration supported by PPPs facilitating infrastructure development and service delivery. All in all, the market trajectory remains upward, with growing investment in healthcare and technology use shaping a more accessible and patient-centered dialysis system.

ASEAN Dialysis Concentrates and Solutions Market Country Insights

Based on country, the ASEAN dialysis concentrates and solutions market is segmented into Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. Indonesia held the largest share in 2024.

The ASEAN dialysis concentrates and solutions market is highly diverse, reflecting varying levels of economic and healthcare development across the member countries. Indonesia and Malaysia are leading markets, supported by advanced healthcare systems, high per-capita healthcare spending, and a strong emphasis on quality of care. These countries also have a dense network of private dialysis centers, greater technology adoption, and established capabilities for home-based care. Although populous nations (such as Vietnam and the Philippines) drive growth with an expanding patient base, their infrastructural and personnel shortages in the profession ultimately restrict market growth. Driven by high demand for treatments that are affordable and easily available, governments invest in expanding public health across these countries. Medical tourism is on the rise in Thailand and Vietnam, resulting in added demand for internationally accredited dialysis products and services.

Overall, ASEAN presents a multi-speed market, requiring tailored strategies to address the spectrum from basic care needs in emerging economies to premium, technology-driven solutions in developed markets.

ASEAN Dialysis Concentrates and Solutions Market Company Profiles

Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc; Nikkiso Co., Ltd; Teleflex Inc; Asahi Kasei Medical Co., Ltd.; Terumo Corp; and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

ASEAN Dialysis Concentrates and Solutions Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

ASEAN Dialysis Concentrates and Solutions Key Sources Referred:

• World Health Organization (WHO)
• United States Renal Data System (USRDS)
• The World Bank Group
• Worldometer
• The Lancet
• International Trade Administration